Skip to main content
Premium Trial:

Request an Annual Quote

Getting to the Bottom of Cancer

Cancer is this era's scourge, and The Economist has a couple of articles on how stem cells can be targeted in tumors. Since most tumors have been found to contain both tumor cells and stem cells, scientists in both basic and clinical labs are using this knowledge to alter their research, opening up to "new ways of thinking about and treating the cancers."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.